Ready to navigate the future of Pricing & Market Access (P&MA) trends in Pharma? Watch our webinar recording to discover how emerging policies and new access models in key healthcare markets will reshape the global pharma landscape in 2025 and beyond.
During this recording we dive into the latest developments in pharma P&MA in key healthcare markets. This session will provide hot-off-the-press insights into key reforms and policy changes to help you prepare for an evolving industry landscape in 2025.
This webinar recording covers:
- Healthcare reforms brought underway in Europe and Canada in 2024 which will come (partly) into effect in 2025, leading to impact on HTA, pricing, and access
- Deep-dive on major European markets providing tangible insights for HTA, pricing, reimbursement, and access launch pricing under new market realities
- Emerging market trends in China driving faster regulatory approval, NRDL process stability and price transparency, and broader early access pathways, as well as increasing momentum and adoption of commercial health insurance programs
- New HTA evaluation framework and access pathways in Saudi-Arabia, increasing requirements for access, while providing new strategic options to expedite access
